IPHA

Innate Pharma
IPHA

8 hedge funds and large institutions have $491K invested in Innate Pharma in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$134K
2
+$33.3K

Top Sellers

1
-$469K
2
-$97.9K
3
-$840
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$260K
2
$131K
3
$63.6K
4
$33.6K
5
$1K
6
$574
7
$560
8
$409